Yervoy (ipilimumab) - BMS
Opdivo (nivolumab) - Ono Pharmaceutical, BMS
Actemra IV (tocilizumab) - Roche, JW Pharma, Chugai Pharmaceutical
A CASE OF CYTOKINE RELEASE SYNDROME FOLLOWING COMBINATION THERAPY WITH IPILIMUMAB AND NIVOLUMAB FOR ADVANCED RENAL CELL CARCINOMA (PubMed, Nihon Hinyokika Gakkai Zasshi) - Oct 13, 2026 - "Corticosteroid therapy was initiated, followed the next day by a single administration of tocilizumab. On day 40, he developed sudden respiratory failure and circulatory collapse, and ultimately passed away. A discussion is presented with reference to the relevant literature." 
Journal • Back Pain • Dermatology • Genito-urinary Cancer • Hypotension • Musculoskeletal Pain • Oncology • Pain • Renal Cell Carcinoma • Respiratory Diseases • Solid Tumor
http://www.ncbi.nlm.nih.gov/pubmed/42864027
 
Hironobu Okugi; Hiroshi Okazaki; Tomohiro Agata; Toshiyuki Nakamura; Tsugufumi Tsukumo
 
Oct 13, 2026
 
Prev Next